Cite
MLA Citation
Y. Shirouchi et al.. “PROGRESSION FREE SURVIVAL AT 12 MONTHS AFTER FIRST‐LINE THERAPY IS ASSOCIATED WITH FAVOURABLE OUTCOMES AFTER FIRST RELAPSE/PROGRESSION IN PERIPHERAL T‐CELL LYMPHOMA.” Hematological oncology, vol. 37, n.d., pp. 469–470. http://access.bl.uk/ark:/81055/vdc_100086208010.0x000048